Global Information
회사소개 | 문의 | 비교리스트

피부과학 관련 각종 제휴 계약 : 계약 조건 및 합의 내용

Global Dermatology Partnering 2014-2020: Deal trends, players and financials

리서치사 Current Partnering, a division of Wildwood Ventures Limited
발행일 2020년 10월 상품 코드 253250
페이지 정보 영문 400+ Pages
가격
US $ 3,495 ₩ 4,033,000 PDF by E-mail (Single User License)
US $ 5,245 ₩ 6,052,000 PDF by E-mail (Multi User License - 2 to 5 Users)
US $ 10,495 ₩ 12,111,000 PDF by E-mail (Single Site License - 6+ Users)
US $ 17,495 ₩ 20,189,000 PDF by E-mail (Global License)


피부과학 관련 각종 제휴 계약 : 계약 조건 및 합의 내용 Global Dermatology Partnering 2014-2020: Deal trends, players and financials
발행일 : 2020년 10월 페이지 정보 : 영문 400+ Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

지난 수년간 피부과학 관련 각종 제휴 계약에 대해 조사분석했으며, 최근의 각종 계약 동향, 대형 계약 및 대형 의약품 업체의 계약 개요, 계약 부문·개발 단계·기술 부문·적응증 부문별 디렉토리 등을 정리하여 전해드립니다.

개요

제1장 서론

제2장 피부과학 관련 각종 계약 동향

  • 서론
  • 지난 수년간 피부과학 관련 제휴
  • 대형 제약회사의 계약 활동
  • 피부과학 관련 사업에 적극적이지 않은 대형 제약회사
  • 피부과학 관련 제휴 : 계약 유형별
  • 피부과학 관련 제휴 : 산업 부문별
  • 피부과학 관련 제휴 : 개발 단계별
  • 피부과학 관련 제휴 : 기술 유형별
  • 피부과학 관련 제휴 : 적응증별
  • 평균 계약기간
    • 선불금
    • 목표 달성 보수
    • 로열티율 등

제3장 주요 계약

  • 서론
  • 주요 계약 : 거래액별
  • 대형 제약회사가 관련된 주요 계약

제4장 대형 제약회사의 계약

  • 서론
  • 제휴 계약 활용법
  • 기업 개요

제5장 계약 디렉토리

  • 서론
  • 계약 유형별
    • 자산 구입
    • 권리 양도
    • 대형 제약회사의 아웃라이선싱
    • 공동개발
    • 공동 R&D
    • 서비스 계약
    • 공동 프로모션
    • 개발
    • 유통
    • 주식 구입
    • 조인트 벤처
    • 라이선싱
    • 소송
    • 융자
    • 제조
    • 마케팅
    • 옵션
    • 프로모션
    • 연구
    • 합의(Settlement) 관련
    • 서브 라이선스
    • 공급
    • 해약
  • 개발 단계별
    • Discovery
    • 처방 설계
    • 출시
    • 단계 I
    • 단계 II
    • 단계 III
    • 전임상
  • 기술 유형별
    • 항체
    • 어세이
    • 생물학적 화합물
    • 바이오소재
    • 임상 검사
    • 디바이스
    • 진단
    • DNA 프로브
    • 약물전달(Drug delivery)
    • 이네이블링 기술(Enabling technology)
    • 설비
    • 게노믹스
    • 천연제품
    • 올리고뉴클레오티드
    • 희귀의약품
    • 펩티드
    • 프로세스
    • 재조합 DNA
    • 재생의학
    • 연구 서비스
    • 연구 공급
    • 스크리닝
    • 소분자
    • 줄기세포

제6장 적응증별

  • 서론
    • 피부과학
    • 여드름
    • 광선각화증
    • 혈관부종
    • 화상
    • 봉와직염
    • 미용
    • 피부염
    • 당뇨병성 족부 궤양
    • 습진
    • 모발 질환
    • 농가진
    • 그렇게양
    • 소양감(Itching)
    • 건선
    • 주사(Rosacea)
    • 일광 손상(Sun damage)
    • 발진
    • 흉터
    • 정맥성 궤양
    • 창상 치유
    • 주름

제7장 제휴 기회

  • 온라인 파트너링
  • 파트너링 이벤트
  • 관련 자료

부록

도표

KSA 12.11.08

The Global Dermatology Partnering 2014-2020 report provides comprehensive understanding and unprecedented access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies

The Global Dermatology Partnering 2014-2020: Deal trends, players and financials report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in Dermatology partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Dermatology partnering agreement structure

Dermatology partnering contract documents

Top Dermatology deals by value

Most active Dermatology dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive dermatology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dermatology deals.

The report presents financial deal terms values for Dermatology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of dermatology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in dermatology dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading dermatology deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active dermatology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to dermatology deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all dermatology partnering deals by specific dermatology target announced since 2014. The chapter is organized by specific dermatology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Report scope

Global Dermatology Partnering 2014-2020 is intended to provide the reader with an in-depth understanding and access to dermatology trends and structure of deals entered into by leading companies worldwide.

Global Dermatology Partnering 2014-2020 includes:

  • Trends in dermatology dealmaking in the biopharma industry since 2014
  • Analysis of dermatology deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to over 600 dermatology deal records
  • The leading dermatology deals by value since 2014
  • The report includes deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles, plus other dermatology indications.

In Global Dermatology Partnering 2014-2020, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Dermatology Partnering 2014-2020 report provides comprehensive access to available deals and contract documents for over 550 dermatology deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

Global Dermatology Partnering 2014 to 2020 provides the reader with the following key benefits:

  • In-depth understanding of dental deal trends since 2014
  • Access dermatology deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between dermatology partner companies
  • Comprehensive access to over 600 links to actual dermatology deals entered into by the world's biopharma companies
  • Indepth review of dermatology deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner dermatology opportunities
  • Uncover companies actively partnering dermatology opportunities

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Dermatology dealmaking

  • 2.1. Introduction
  • 2.2. Dermatology partnering over the years
  • 2.3. Dermatology partnering by deal type
  • 2.4. Dermatology partnering by industry sector
  • 2.5. Dermatology partnering by stage of development
  • 2.6. Dermatology partnering by technology type
  • 2.7. Dermatology partnering by therapeutic indication

Chapter 3 -Financial deal terms for Dermatology partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for Dermatology partnering
  • 3.3. Dermatology partnering headline values
  • 3.4. Dermatology deal upfront payments
  • 3.5. Dermatology deal milestone payments
  • 3.6. Dermatology royalty rates

Chapter 4 - Leading Dermatology deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in Dermatology partnering
  • 4.3. List of most active dealmakers in Dermatology
  • 4.4. Top Dermatology deals by value

Chapter 5 - Dermatology contract document directory

  • 5.1. Introduction
  • 5.2. Dermatology partnering deals where contract document available

Chapter 6 - Dermatology dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by Dermatology therapeutic target

Appendices

  • Appendix 1 - Directory of Dermatology deals by company A-Z 2014 to 2020
  • Appendix 2 - Directory of Dermatology deals by deal type 2014 to 2020
  • Appendix 3 - Directory of Dermatology deals by stage of development 2014 to 2020
  • Appendix 4 - Directory of Dermatology deals by technology type 2014 to 2020
  • Further reading on dealmaking
  • Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent report titles from CurrentPartnering
  • Table of figures
  • Figure 1: Dermatology partnering since 2014
  • Figure 2: Dermatology partnering by deal type since 2014
  • Figure 3: Dermatology partnering by industry sector since 2014
  • Figure 4: Dermatology partnering by stage of development since 2014
  • Figure 5: Dermatology partnering by technology type since 2014
  • Figure 6: Dermatology partnering by indication since 2014
  • Figure 7: Dermatology deals with a headline value
  • Figure 8: Dermatology deals with upfront payment values
  • Figure 9: Dermatology deals with milestone payment
  • Figure 10: Dermatology deals with royalty rates
  • Figure 11: Active Dermatology dealmaking activity- 2014 to 2020
  • Figure 12: Top Dermatology deals by value since 2014
Back to Top
전화 문의
F A Q